![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Under the agreement, Biddle will serve as the exclusive supplier of TC220, a proprietary boronated amino acid analog developed by TAE Life Sciences to support BNCT cancer treatment.
Lead Product(s): TC-220
Therapeutic Area: Oncology Product Name: TC220
Highest Development Status: IND EnablingProduct Type: Large molecule
Partner/Sponsor/Collaborator: TAE Life Sciences
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement August 15, 2023